我国《药品差比价规则(试行)》分析
朱明蕾;史录文
【期刊名称】《中国药房》 【年(卷),期】2009(020)028
【摘要】目的:为进一步完善国家发改委<药品差比价规则(试行)>(下简称<规则>)提供参考.方法:回顾我国药品价格管理历程,以北京市12家医院为例分析<规则>实施后取得的成效及局限,提出完善建议.结果与结论:<规则>在药品定价管理方面形成了较为统一规范的评价标准、计算方法,乃至整体的评价体系,降低了药品价格管理中的人为因素影响和行政管理成本,提高了政府定价效率,但仍需不断完善其中不合理的差比价系数和计算方法.%OBJECTIVE: To provide reference for perfecting the \by National Development and Reform Commission. METHODS: To review the drug price management course in China, analyze the effects and limitations since the initiation of \of Drug Price Difference\improvement. RESULTS & CONCLUSIONS: \of Drug Price Difference\has contributed to the formation of unified and standard evaluation criterion and computation method or even the holistic evaluation system in drug pricing management, the lowering of the costs of human factors and administrative management in drug price management and the improvement of the governmental pricing efficiency. However, efforts should be taken to improve the
我国《药品差比价规则(试行)》分析
